CATALOGO DEI PRODOTTI DELLA RICERCA

CALABRESE, Massimiliano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.410
NA - Nord America 5.183
AS - Asia 4.286
SA - Sud America 709
AF - Africa 168
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 3
Totale 16.775
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.029
RU - Federazione Russa 3.157
SG - Singapore 1.698
CN - Cina 1.272
GB - Regno Unito 688
IT - Italia 660
BR - Brasile 592
HK - Hong Kong 423
DE - Germania 385
SE - Svezia 328
VN - Vietnam 308
FR - Francia 302
FI - Finlandia 281
IE - Irlanda 256
KR - Corea 126
TR - Turchia 124
CA - Canada 84
ID - Indonesia 77
UA - Ucraina 59
AT - Austria 54
IN - India 52
NL - Olanda 52
PL - Polonia 51
AR - Argentina 50
JP - Giappone 49
MX - Messico 45
ZA - Sudafrica 41
ES - Italia 36
TG - Togo 35
BJ - Benin 32
BD - Bangladesh 29
BE - Belgio 22
EC - Ecuador 17
MA - Marocco 15
AE - Emirati Arabi Uniti 14
CO - Colombia 13
UZ - Uzbekistan 13
PY - Paraguay 12
IQ - Iraq 11
LT - Lituania 11
MK - Macedonia 11
AU - Australia 10
AZ - Azerbaigian 10
EG - Egitto 10
CZ - Repubblica Ceca 8
IL - Israele 8
KE - Kenya 8
CL - Cile 7
HR - Croazia 7
JO - Giordania 7
PK - Pakistan 7
DZ - Algeria 6
PE - Perù 6
PT - Portogallo 6
QA - Qatar 6
SA - Arabia Saudita 6
CH - Svizzera 5
DO - Repubblica Dominicana 5
PH - Filippine 5
CY - Cipro 4
GY - Guiana 4
KZ - Kazakistan 4
LA - Repubblica Popolare Democratica del Laos 4
MD - Moldavia 4
RS - Serbia 4
SN - Senegal 4
UY - Uruguay 4
AM - Armenia 3
BG - Bulgaria 3
HN - Honduras 3
KG - Kirghizistan 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
OM - Oman 3
RO - Romania 3
TN - Tunisia 3
TW - Taiwan 3
AL - Albania 2
BO - Bolivia 2
BY - Bielorussia 2
CG - Congo 2
CI - Costa d'Avorio 2
DK - Danimarca 2
GD - Grenada 2
GR - Grecia 2
HU - Ungheria 2
IR - Iran 2
KH - Cambogia 2
LU - Lussemburgo 2
ML - Mali 2
NC - Nuova Caledonia 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
SC - Seychelles 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
Totale 16.749
Salva come PNG Salva come JPEG
Città #
Moscow 1.108
Chandler 682
Singapore 678
Ashburn 655
Dallas 645
Southend 490
Hong Kong 418
Beijing 267
Dublin 252
Verona 221
Munich 186
Jacksonville 165
Woodbridge 151
Helsinki 149
Los Angeles 139
Ann Arbor 133
New York 133
The Dalles 122
Princeton 100
Redmond 97
Houston 96
Lawrence 93
Istanbul 92
São Paulo 81
Ho Chi Minh City 80
Wilmington 79
Jinan 71
Redondo Beach 68
Jakarta 63
Buffalo 55
Hanoi 53
Dong Ket 52
London 51
Nanjing 48
Warsaw 46
Lancaster 45
Lappeenranta 44
Shenyang 44
Sindelfingen 44
Tianjin 44
Santa Clara 43
Milan 42
Montreal 42
Columbus 41
Turku 41
Hebei 39
Tokyo 39
Seattle 38
Lomé 35
Council Bluffs 33
Cotonou 32
Johannesburg 32
Nuremberg 32
Redwood City 32
Washington 32
Brooklyn 30
Atlanta 29
Seoul 29
Changsha 27
Chicago 27
Chennai 26
Denver 26
Guangzhou 26
Vienna 26
Zhengzhou 26
Haikou 25
Ningbo 24
Amsterdam 23
Stockholm 23
Phoenix 22
Taizhou 22
Brussels 21
Orem 21
Boardman 20
Poplar 20
Rome 20
Mexico City 19
Nanchang 19
Falkenstein 17
Hangzhou 17
Norwalk 17
Paris 17
Bologna 16
Manchester 16
Ankara 15
Haiphong 15
Rio de Janeiro 15
San Francisco 15
Des Moines 14
Dongguan 14
Padova 13
Sant'Ambrogio di Valpolicella 13
Taiyuan 13
Toronto 13
Belo Horizonte 12
Boston 12
Frankfurt am Main 12
Fuzhou 12
Porto Alegre 12
Brasília 11
Totale 9.455
Salva come PNG Salva come JPEG
Nome #
Microstructural modulations in the hippocampus allow to characterizing relapsing-remitting versus primary progressive multiple sclerosis 371
Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis 262
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 224
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 191
QTc interval in patients with multiple sclerosis: an inference from the insula of Reil? 189
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 185
A case of acute fulminant multiple sclerosis treated with alemtuzumab 185
Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patients 184
The CSF profile linked to cortical damage predicts Multiple Sclerosis activity 183
Cerebrospinal fluid IgM levels in association with inflammatory pathways in multiple sclerosis patients 179
A case of epilepsy in multiple sclerosis: Three-dimensional double inversion recovery sequences revealed cortical dysplasia 177
Iron loss of thalamic nuclei evaluated with quantitative susceptibility mapping is related to intrathecal macrophages activity and cortical pathology of multiple sclerosis 172
Can DTI and 3D-SHORE based indices differentiate RRMS from PMS Patients? 166
Dimethyl fumarate: a possible exit strategy from natalizumab treatment in patients with multiple sclerosis at risk for severe adverse events 162
The prognostic value of white-matter selective double inversion recovery mri sequence in multiple sclerosis: an exploratory study 161
Assessing response to interferon-β in a multicenter dataset of patients with MS 159
Correlation between cerebrospinal fluid markers of neurodegeneration and MRI measures of gray matter pathology in multiple sclerosis 158
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy. 157
Explainable 3D-CNN for multiple sclerosis patients stratication 157
Response to Nagai et al. 155
A videogame-based approach to measuring information processing speed in multiple sclerosis patients 154
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 153
Executive functioning affects verbal learning process in multiple sclerosis patients: Behavioural and imaging results 153
Epilepsy in multiple sclerosis: The role of temporal lobe damage 153
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 152
Coping strategies and their impact on quality of life and physical disability of people with multiple sclerosis 152
CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis 148
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study 147
Heterogeneity of cortical lesion susceptibility mapping in multiple sclerosis 146
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 144
Up-regulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients 142
Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis 141
The use of the central vein sign in the diagnosis of multiple sclerosis: a systematic review and meta-analysis 140
Unraveling the MRI-Based Microstructural Signatures Behind Primary Progressive and Relapsing-Remitting Multiple Sclerosis Phenotypes 140
Volume changes of thalamus, hippocampus and cerebellum are associated with specific CSF profile in MS 140
A novel prognostic score to assess the risk of progression in relapsing-remitting multiple sclerosis patients 139
Automatic segmentation of gray matter multiple sclerosis lesions on DIR images 138
CSF levels of CXCL12 and osteopontin as early markers of primary progressive multiple sclerosis 136
The diagnosis of multiple sclerosis: pinpointing the concept of "no better explanation" 135
Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy 135
Visual-attentional load unveils slowed processing speed in multiple sclerosis patients: a pilot study with a tablet-based videogame 134
Changes in cerebrospinal fluid balance of TNF and TNF receptors in naïve multiple sclerosis patients: early involvement in compartmentalised intrathecal inflammation 134
Interpretable Deep Learning as a means for decrypting disease signature in Multiple Sclerosis 133
Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study 131
Long-term clinical, cognitive and MRI characteristics of patients with untreated benign multiple sclerosis: a natural history study 129
Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients 129
Lost in classification: lower cognitive functioning in apparently cognitive normal newly diagnosed RRMS patients 128
Effect of glatiramer acetate on cerebral grey matter pathology in patients with relapsing-remitting multiple sclerosis 127
Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study 126
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis 125
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 125
Correlating Dti and 3d-Shore Based Indices with Neurological Disability Scores of Multiple Sclerosis Patients 125
Increased cortical lesion load and CSF cytokines in oligoclonal band positive MS patients 124
Microstructural MRI Correlates of Cognitive Impairment in Multiple Sclerosis: The Role of Deep Gray Matter 124
Multicenter evaluation of AI-generated DIR and PSIR for cortical and juxtacortical multiple sclerosis lesion detection 123
The effect of fingolimod on focal and diffuse grey matter damage in active MS patients 122
Gray matter MRI differentiates neuromyelitis optica from multiple sclerosis using random forest 122
Two years' effect of dimethyl fumarate on focal and diffuse gray matter pathology in multiple sclerosis 120
CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray Matter Damage 120
Exploring the origins of grey matter damage in multiple sclerosis. 119
False memories in relapsing remitting multiple sclerosis patients: A preliminary investigation with the DRM paradigm 119
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 118
Diffusion MRI and silver standard masks to improve CNN-based thalamus segmentation 118
Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs 117
Atypical myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review 117
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia 116
Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability in Early Multiple Sclerosis 113
Repeated passive mobilization to stimulate vascular function in individuals of advanced age who are chronically bedridden. A randomized controlled trial 113
"What is hidden behind the mask?" Facial emotion recognition at the time of COVID-19 pandemic in cognitively normal multiple sclerosis patients 112
"Ependymal-in" gradient of thalamic damage in progressive multiple sclerosis 112
Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity 110
Cortical lesions at diagnosis predict long-term cognitive impairment in multiple sclerosis: a 20-year study 110
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis 109
CSF TNF and osteopontin levels correlate with the response to dimethyl fumarate in early multiple sclerosis 108
CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis 107
Potential neuroprotective effect of Fingolimod in multiple sclerosis and its association with clinical variables 107
Impact of model selection procedure on Deep Neural Networks ensemble for the Choroid Plexus segmentation in Multiple Sclerosis 106
Explainable deep learning for decrypting disease signatures in multiple sclerosis 106
Cluster analysis showed long-term cognition can be predicted by looking at regional grey matter atrophy in the first two years of multiple sclerosis course 104
Multiple sclerosis and epilepsy: much more than a coincidence 104
Cortical lesion counts by double inversion recovery should be part of the MRI monitoring process for all MS patients: yes. 104
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients 103
The vascular side of chronic bed rest: when a therapeutic approach becomes deleterious 103
Early multiple sclerosis: diagnostic challenges in clinically and radiologically isolated syndrome patients 102
ASCHOPLEX: A generalizable approach for the automatic segmentation of choroid plexus 102
Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI 101
The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse? 100
Making Visible the Invisible: Automatically Measured Global and Regional Brain Volume Is Associated with Cognitive Impairment and Fatigue in Multiple Sclerosis 99
Multiple sclerosis diagnosis and its differential diagnosis in patients presenting with type four 'mirror pattern' CSF oligoclonal bands 99
Heterogeneity of cortical lesions in multiple sclerosis: An MRI perfusion study 98
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: an Italian multi-centre study 98
Intrathecal versus peripheral inflammatory protein profile in MS patients at diagnosis: a comprehensive investigation on serum and CSF 98
Therapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophy. 97
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study. 97
Multivariate data analysis suggests the link between brain microstructure and cognitive impairment in multiple sclerosis 97
Chronic bedridden condition is reflected by substantial changes in plasma inflammatory profile 96
Shared imaging markers of fatigue across multiple sclerosis, aquaporin-4 antibody neuromyelitis optica spectrum disorder and MOG antibody disease 96
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis 95
Early regional cerebral grey matter damage predicts long-term cognitive impairment phenotypes in multiple sclerosis: a 20-year study 93
Slowing processing speed is associated with cognitive fatigue in newly diagnosed multiple sclerosis patients 92
Totale 13.381
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.058
article - articoli 57.554
book - libri 0
conference - conferenze 6.083
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 421
Totale 128.116
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021357 0 0 0 0 0 75 32 20 49 34 68 79
2021/2022870 48 263 5 125 18 19 34 53 27 30 64 184
2022/20231.895 116 244 158 337 129 415 45 114 220 22 53 42
2023/20241.235 38 88 105 132 124 238 102 77 17 94 154 66
2024/20253.674 140 169 144 615 159 203 205 223 620 250 315 631
2025/20267.170 720 580 722 1.847 2.968 333 0 0 0 0 0 0
Totale 17.041